Obidiugwu Kenrik Duru
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Obidiugwu Kenrik Duru has a total of 278 co-authors. Here are the top co-authors by number of shared publications:
Carol M. Mangione
Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, California
15 shared publicationsNorman Turk
David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA
10 shared publications- Arleen F. Brown
Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA
9 shared publications - Carol M. Mangione
Division of General Internal Medicine & Health Services Research, David Geffen School of Medicine, University of California, Los Angeles (UCLA) , Los Angeles, CA
9 shared publications Keith C. Norris
Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA
6 shared publicationsSusan L. Ettner
David Geffen School of Medicine, UCLA
6 shared publications
Latest Publications
- Open Access
- 12 January 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e80534
Evaluating the Acceptability of Using Virtual Reality to Promote Physical Activity Among Latino, Latina, and Latine Adults With Cardiometabolic Risk Factors and Obesity in Underresourced Settings: Protocol for a Qualitative Focus Group Study
Background: Obesity represents a significant public health challenge in the United States, particularly among Latino, Latina, and Latine communities and those in underresourced settings. Virtual reality (VR) is a new and innovative technology that can promote physical activity and has the potential to overcome some structural barriers. However, there are few studies that explore the acceptability of using this new technology among high-risk groups in underresourced settings. Objective: We outline a community-informed protocol for conducting focus groups with Latino, Latina, and Latine adults who have cardiometabolic risk factors and obesity residing in underresourced communities. The focus groups will assess the acceptability of a culturally aligned VR program to promote physical activity. Methods: Using a community-engaged approach informed by community health workers and a community advisory board, we delivered an immersive VR dance experience to Latino, Latina, and Latine adult participants with cardiometabolic risk factors and obesity. Following the VR experience, we conducted semistructured focus group interviews to assess acceptability guided by the theoretical framework of acceptability. Data collection included a baseline demographic survey and focus group discussions to evaluate participant experiences and the VR program’s acceptability. Results: As of April 2025, we have completed 7 focus groups with 44 participants across 3 age groups: 18 to 29 years, 30 to 49 years, and 50 to 70 years. Data collection was completed in May 2025, and study findings are expected to be published in February 2026. Conclusions: The fully analyzed data from this study will offer insights into leveraging VR as an innovative tool for promoting physical activity in underserved populations, contributing to the broader literature on digital health equity and obesity prevention.
- 12 January 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e80534
Open AccessEvaluating the Acceptability of Using Virtual Reality to Promote Physical Activity Among Latino, Latina, and Latine Adults With Cardiometabolic Risk Factors and Obesity in Underresourced Settings: Protocol for a Qualitative Focus Group Study
Background: Obesity represents a significant public health challenge in the United States, particularly among Latino, Latina, and Latine communities and those in underresourced settings. Virtual reality (VR) is a new and innovative technology that can promote physical activity and has the potential to overcome some structural barriers. However, there are few studies that explore the acceptability of using this new technology among high-risk groups in underresourced settings. Objective: We outline a community-informed protocol for conducting focus groups with Latino, Latina, and Latine adults who have cardiometabolic risk factors and obesity residing in underresourced communities. The focus groups will assess the acceptability of a culturally aligned VR program to promote physical activity. Methods: Using a community-engaged approach informed by community health workers and a community advisory board, we delivered an immersive VR dance experience to Latino, Latina, and Latine adult participants with cardiometabolic risk factors and obesity. Following the VR experience, we conducted semistructured focus group interviews to assess acceptability guided by the theoretical framework of acceptability. Data collection included a baseline demographic survey and focus group discussions to evaluate participant experiences and the VR program’s acceptability. Results: As of April 2025, we have completed 7 focus groups with 44 participants across 3 age groups: 18 to 29 years, 30 to 49 years, and 50 to 70 years. Data collection was completed in May 2025, and study findings are expected to be published in February 2026. Conclusions: The fully analyzed data from this study will offer insights into leveraging VR as an innovative tool for promoting physical activity in underserved populations, contributing to the broader literature on digital health equity and obesity prevention.
- Open Access
- 27 November 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1)
Census-tract broadband connectivity and the risk of diabetes, hypertension and obesity/overweight in California
Background: In the digital age, a growing literature suggests that broadband coverage and high-speed internet access are social determinants of health. However, there is little research on regional broadband connectivity and its relationship to the prevalence of common health conditions such as type 2 diabetes, hypertension, and obesity/overweight. Using the California Health Interview Survey (CHIS) and US Census data, we aimed to assess if local broadband connectivity at the census tract level was related to prevalence of cardiometabolic dysfunction (diabetes, hypertension, and obesity/overweight) in these census tracts. Methods : Using a cross-sectional design, we analyzed data from 2019 California Health Interview Survey (CHIS) respondents aged 18 years or older (n = 21,905). Broadband connectivity and population density at the census tract level was determined from 2010 US Census data. Health information, secondary predictors, and covariates were self-reported by California Health Interview Survey CHIS respondents. Results: The prevalence of type 2 diabetes was greater in broadband connectivity areas with less than 40% high-speed connectivity (OR 2.4, 95% CI 1.6–3.7, p < 0.001) as compared with broadband connectivity areas with greater than 80% high-speed connectivity. As compared to areas with greater than 80% high-speed connectivity, we did not find differences in diabetes prevalence for areas with 40–60% high-speed connectivity (OR 1.2, 95% CI 0.8–1.7) or areas with 60–80% high-speed connectivity (OR 1.2, 95% CI 0.97–1.4). There were trends toward greater hypertension prevalence in areas with lower high-speed broadband connectivity as compared to higher broadband connectivity, but none of the differences reached statistical significance (all p values between 0.05 and 0.1). We did not find statistically differences in the prevalence of obesity/overweight for areas with different penetration of high-speed broadband connectivity. Conclusions: In California, the prevalence of cardiometabolic conditions, particularly type 2 diabetes, is highest in areas with lowest broadband connectivity. More research is needed to better understand the direct relationship between broadband connectivity, the usage of online health resources and the management or prevention of cardiometabolic dysfunction.
- 27 November 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1)
Open AccessCensus-tract broadband connectivity and the risk of diabetes, hypertension and obesity/overweight in California
Background: In the digital age, a growing literature suggests that broadband coverage and high-speed internet access are social determinants of health. However, there is little research on regional broadband connectivity and its relationship to the prevalence of common health conditions such as type 2 diabetes, hypertension, and obesity/overweight. Using the California Health Interview Survey (CHIS) and US Census data, we aimed to assess if local broadband connectivity at the census tract level was related to prevalence of cardiometabolic dysfunction (diabetes, hypertension, and obesity/overweight) in these census tracts. Methods : Using a cross-sectional design, we analyzed data from 2019 California Health Interview Survey (CHIS) respondents aged 18 years or older (n = 21,905). Broadband connectivity and population density at the census tract level was determined from 2010 US Census data. Health information, secondary predictors, and covariates were self-reported by California Health Interview Survey CHIS respondents. Results: The prevalence of type 2 diabetes was greater in broadband connectivity areas with less than 40% high-speed connectivity (OR 2.4, 95% CI 1.6–3.7, p < 0.001) as compared with broadband connectivity areas with greater than 80% high-speed connectivity. As compared to areas with greater than 80% high-speed connectivity, we did not find differences in diabetes prevalence for areas with 40–60% high-speed connectivity (OR 1.2, 95% CI 0.8–1.7) or areas with 60–80% high-speed connectivity (OR 1.2, 95% CI 0.97–1.4). There were trends toward greater hypertension prevalence in areas with lower high-speed broadband connectivity as compared to higher broadband connectivity, but none of the differences reached statistical significance (all p values between 0.05 and 0.1). We did not find statistically differences in the prevalence of obesity/overweight for areas with different penetration of high-speed broadband connectivity. Conclusions: In California, the prevalence of cardiometabolic conditions, particularly type 2 diabetes, is highest in areas with lowest broadband connectivity. More research is needed to better understand the direct relationship between broadband connectivity, the usage of online health resources and the management or prevention of cardiometabolic dysfunction.
- Open Access
- 14 November 2025
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 9 (6) , 100671
A Systematic Literature Review of Coordinated Care in Cardiovascular-Kidney-Metabolic Conditions
- 14 November 2025
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 9 (6) , 100671
Open AccessA Systematic Literature Review of Coordinated Care in Cardiovascular-Kidney-Metabolic Conditions
- Open Access
Type 2 Diabetes Risk Perception and Health Behaviors Among Women with History of Gestational Diabetes Mellitus: A Retrospective Analysis
Background/Objectives: History of gestational diabetes mellitus (GDM) is a strong risk factor in the development of type 2 diabetes (T2D). We sought to examine the association between perceived risk of developing T2D and relevant health behaviors in this population. Methods: We analyzed self-reported survey items and objective electronic health record data of participants in the Gestational diabetes Risk Attenuation for New Diabetes (GRAND) Study, a multisite randomized control trial testing the effectiveness of shared decision-making for women with elevated body mass index (BMI), prediabetes and history of GDM. Data on demographics, health behaviors, and perceived T2D risk were self-reported. We ran four regression models to study the association between women’s perceived risk of developing T2D and four key health behaviors: (1) physical activity, (2) consumption of sugar-sweetened beverages, (3) consumption of ultra-processed foods, and (4) consumption of meals prepared outside the home. All models were adjusted for age, race, ethnicity, income, HbA1c, BMI, family history of T2D, and study arm. Results: Our sample included 242 women who on average were 41 years old (±6 years) with BMI of 32.7 (±6.9 kg/m2). Perceived risk of developing T2D was not significantly associated with physical activity, consumption of sugar-sweetened beverages, ultra-processed food consumption, or meals prepared outside of the home. Higher BMI was significantly associated with increased consumption of sugar-sweetened beverages (OR 1.05, 95% CI 1.01–1.10), but not other health behaviors. Conclusions: We found perceived risk of developing T2D was not independently associated with four key health behaviors. Women with GDM are at high risk of developing T2D and may benefit from tailored or more intensive strategies promoting health behavior changes shown to lower T2D risk.
Open AccessType 2 Diabetes Risk Perception and Health Behaviors Among Women with History of Gestational Diabetes Mellitus: A Retrospective Analysis
Background/Objectives: History of gestational diabetes mellitus (GDM) is a strong risk factor in the development of type 2 diabetes (T2D). We sought to examine the association between perceived risk of developing T2D and relevant health behaviors in this population. Methods: We analyzed self-reported survey items and objective electronic health record data of participants in the Gestational diabetes Risk Attenuation for New Diabetes (GRAND) Study, a multisite randomized control trial testing the effectiveness of shared decision-making for women with elevated body mass index (BMI), prediabetes and history of GDM. Data on demographics, health behaviors, and perceived T2D risk were self-reported. We ran four regression models to study the association between women’s perceived risk of developing T2D and four key health behaviors: (1) physical activity, (2) consumption of sugar-sweetened beverages, (3) consumption of ultra-processed foods, and (4) consumption of meals prepared outside the home. All models were adjusted for age, race, ethnicity, income, HbA1c, BMI, family history of T2D, and study arm. Results: Our sample included 242 women who on average were 41 years old (±6 years) with BMI of 32.7 (±6.9 kg/m2). Perceived risk of developing T2D was not significantly associated with physical activity, consumption of sugar-sweetened beverages, ultra-processed food consumption, or meals prepared outside of the home. Higher BMI was significantly associated with increased consumption of sugar-sweetened beverages (OR 1.05, 95% CI 1.01–1.10), but not other health behaviors. Conclusions: We found perceived risk of developing T2D was not independently associated with four key health behaviors. Women with GDM are at high risk of developing T2D and may benefit from tailored or more intensive strategies promoting health behavior changes shown to lower T2D risk.
- Open Access
- 29 July 2025
- Published by Elsevier in AJPM Focus
- Vol. 4 (6) , 100401
Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program
- 29 July 2025
- Published by Elsevier in AJPM Focus
- Vol. 4 (6) , 100401
Open AccessReal-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program
- Open Access
- 2 June 2025
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (6) , e2511804
Care Coordination for High-Need, High-Cost Commercially Insured Patients
Importance: High-need, high-cost (HNHC) patients account for 5% of the US population yet represent nearly half of health care spending.Objective: To evaluate whether national care coordination could reduce health care cost and utilization in a commercially insured HNHC population.Design, Setting, and Participants: This national, 2-arm randomized clinical trial with intention-to-treat and instrumental variable analyses included patients aged 18 years or older who were defined as HNHC according to a proprietary model (in the top 5% of spend within a rolling 12-month claims utilization window and projected to remain in the top 5% over the subsequent 12 months). Patients were randomized from January 2018 to October 2019. Data were analyzed from January 1 to December 31, 2024.Intervention: Participants were randomized monthly 60:40 to telephonic care coordination from a registered nurse, including medication review, a barriers-to-care survey, addressing urgent coordination needs (eg, patient unable to fill prescriptions), development of a case management plan addressing identified clinical risk factors, and establishing an outreach time frame, or to the control group with usual care. The nurse contacted patients over the 60 days after enrollment until all risk factors included in the management plan were addressed.Main Outcomes and Measures: The main outcomes were mean monthly emergency department visits, inpatient hospitalizations, and total plan cost (medical and pharmacy) over 12 months following the index date, defined as the enrollment date for intervention participants or the randomly generated synthetic enrollment date for nonparticipants. Outcomes were examined separately among patients with diabetes.Results: The analytic sample included 93 379 HNHC patients with a mean (SD) age of 46 (12) years (54% female). In intention-to-treat analyses, there were no differences between groups in mean (SE) monthly emergency department visits (0.033 [0.001] for control vs 0.033 [0.001] for treatment; mean difference [SE], 0 [0]; 95% CI, −0.001 to 0.002; P = .69), inpatient hospitalizations (0.009 [0] for control vs 0.010 [0] for treatment; mean difference [SE], 0.001 [0]; 95% CI, 0-0.002; P = .06), or cost (total: $2507 [$32] for control vs $2568 [$26] for treatment; mean difference [SE], $60 [$41]; 95% CI, −$20 to $140; P = .14). In the instrumental variable analyses and in the subsample with diabetes, no evidence of statistically significant reductions in these outcomes were found.Conclusions and Relevance: In this randomized clinical trial of a national care coordination intervention, neither health care cost nor acute care utilization was reduced in the intervention group compared with the control group. The results emphasize the challenges of improving efficiency of care in a complex HNHC population with escalating health care costs.Trial Registration: ClinicalTrials.gov Identifier: NCT04415515
- 2 June 2025
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (6) , e2511804
Open AccessCare Coordination for High-Need, High-Cost Commercially Insured Patients
Importance: High-need, high-cost (HNHC) patients account for 5% of the US population yet represent nearly half of health care spending.Objective: To evaluate whether national care coordination could reduce health care cost and utilization in a commercially insured HNHC population.Design, Setting, and Participants: This national, 2-arm randomized clinical trial with intention-to-treat and instrumental variable analyses included patients aged 18 years or older who were defined as HNHC according to a proprietary model (in the top 5% of spend within a rolling 12-month claims utilization window and projected to remain in the top 5% over the subsequent 12 months). Patients were randomized from January 2018 to October 2019. Data were analyzed from January 1 to December 31, 2024.Intervention: Participants were randomized monthly 60:40 to telephonic care coordination from a registered nurse, including medication review, a barriers-to-care survey, addressing urgent coordination needs (eg, patient unable to fill prescriptions), development of a case management plan addressing identified clinical risk factors, and establishing an outreach time frame, or to the control group with usual care. The nurse contacted patients over the 60 days after enrollment until all risk factors included in the management plan were addressed.Main Outcomes and Measures: The main outcomes were mean monthly emergency department visits, inpatient hospitalizations, and total plan cost (medical and pharmacy) over 12 months following the index date, defined as the enrollment date for intervention participants or the randomly generated synthetic enrollment date for nonparticipants. Outcomes were examined separately among patients with diabetes.Results: The analytic sample included 93 379 HNHC patients with a mean (SD) age of 46 (12) years (54% female). In intention-to-treat analyses, there were no differences between groups in mean (SE) monthly emergency department visits (0.033 [0.001] for control vs 0.033 [0.001] for treatment; mean difference [SE], 0 [0]; 95% CI, −0.001 to 0.002; P = .69), inpatient hospitalizations (0.009 [0] for control vs 0.010 [0] for treatment; mean difference [SE], 0.001 [0]; 95% CI, 0-0.002; P = .06), or cost (total: $2507 [$32] for control vs $2568 [$26] for treatment; mean difference [SE], $60 [$41]; 95% CI, −$20 to $140; P = .14). In the instrumental variable analyses and in the subsample with diabetes, no evidence of statistically significant reductions in these outcomes were found.Conclusions and Relevance: In this randomized clinical trial of a national care coordination intervention, neither health care cost nor acute care utilization was reduced in the intervention group compared with the control group. The results emphasize the challenges of improving efficiency of care in a complex HNHC population with escalating health care costs.Trial Registration: ClinicalTrials.gov Identifier: NCT04415515
- Open Access
Identifying pre-diabetes ‘hotspots’ in Northern California using geospatial analysis: opportunities to target diabetes prevention strategies and improve health equity
Objectives: The US Preventive Services Task Force recommends screening of adults aged 35–70 with a body mass index ≥25 kg/m 2 for type 2 diabetes and referral of individuals who screen positive for pre-diabetes to evidence-based prevention strategies. The diabetes burden in the USA is predicted to triple by 2060 necessitating strategic diabetes prevention efforts, particularly in areas of highest need. This study aimed to identify pre-diabetes hotspots using geospatial mapping to inform targeted diabetes prevention strategies. A ‘hotspot’ is defined as a cluster of 3 or more neighbouring census tracts with elevated pre-diabetes prevalence. Design: A cross-sectional study using ArcGIS software to geospatially map pre-diabetes prevalence hotspots. We used health system and census data to identify pre-diabetes hotspots using a systematic five-step geoprocessing approach that made use of incremental spatial autocorrelation and Getis-Ord Gi*. Setting: This study was set in Kaiser Permanente Northern California (KPNC), an integrated health delivery system with over four million members. Participants: KPNC adults ages 35–70 who underwent a haemoglobin A1c (HbA1c) or fasting plasma glucose (FPG) screening test in 2019 were mapped to census tracts in Northern California. People were considered to have pre-diabetes with an HbA1c of 5.7%–6.4% (39–46 mmol/mol) or FPG 100–125 mg/dL. Primary and secondary outcome measures: Individual and census-level characteristics were compared between hotspots and non-hotspots using χ 2 and Wilcoxon rank sum tests, as well as risk differences (RDs) and Hodges-Lehmann (HL) estimates of location shift. Individual-level characteristics were derived from electronic health records and administrative data, while census-level characteristics were derived from the 2019 American Community Survey. Results: A total of 760 044 adults met the study inclusion criteria and 40% had pre-diabetes. Individuals in pre-diabetes hotspots were less likely to be non-Hispanic white (33.6% vs 50.6%, RD: −17.04%, 95% CI –17.26% to –16.81%, p<0.0001) and more likely to have overweight or obesity (72.2% vs 69.2%, RD: 2.95%, 95% CI 2.73% to 3.16%, p<0.0001). Census tracts within hotspots had lower levels of household income (HL estimate: −3651.00, 95% CI –7256.00 to –25.00), per cent of adults with bachelor’s degrees or higher (HL estimate: −9.08, 95% CI –10.94 to –7.24) and median home values (HL estimate: −113 200.00, 95% CI –140 600.00 to –85 700.00) and higher rates of household poverty (HL estimate: 0.96, 95% CI 0.55 to 1.37), unemployment (HL estimate: 0.39, 95% CI 0.24 to 0.54), household public assistance (HL estimate: 0.97, 95% CI 0.76 to 1.18) and per cent receiving Medicaid (HL estimate: 4.56, 95% CI 3.40 to 5.76) (p<0.05 for all). Conclusions: We found that individual-level and census tract-level socioeconomic status, obesity prevalence and race and ethnicity categories of patients living in pre-diabetes hotspots differed from those not identified as a hotspot. Policy-makers and care providers can use this information to target diabetes prevention resources and outreach by enacting policies that provide insurance coverage for low-income populations and placing diabetes prevention programmes in communities with highest need.
Open AccessIdentifying pre-diabetes ‘hotspots’ in Northern California using geospatial analysis: opportunities to target diabetes prevention strategies and improve health equity
Objectives: The US Preventive Services Task Force recommends screening of adults aged 35–70 with a body mass index ≥25 kg/m 2 for type 2 diabetes and referral of individuals who screen positive for pre-diabetes to evidence-based prevention strategies. The diabetes burden in the USA is predicted to triple by 2060 necessitating strategic diabetes prevention efforts, particularly in areas of highest need. This study aimed to identify pre-diabetes hotspots using geospatial mapping to inform targeted diabetes prevention strategies. A ‘hotspot’ is defined as a cluster of 3 or more neighbouring census tracts with elevated pre-diabetes prevalence. Design: A cross-sectional study using ArcGIS software to geospatially map pre-diabetes prevalence hotspots. We used health system and census data to identify pre-diabetes hotspots using a systematic five-step geoprocessing approach that made use of incremental spatial autocorrelation and Getis-Ord Gi*. Setting: This study was set in Kaiser Permanente Northern California (KPNC), an integrated health delivery system with over four million members. Participants: KPNC adults ages 35–70 who underwent a haemoglobin A1c (HbA1c) or fasting plasma glucose (FPG) screening test in 2019 were mapped to census tracts in Northern California. People were considered to have pre-diabetes with an HbA1c of 5.7%–6.4% (39–46 mmol/mol) or FPG 100–125 mg/dL. Primary and secondary outcome measures: Individual and census-level characteristics were compared between hotspots and non-hotspots using χ 2 and Wilcoxon rank sum tests, as well as risk differences (RDs) and Hodges-Lehmann (HL) estimates of location shift. Individual-level characteristics were derived from electronic health records and administrative data, while census-level characteristics were derived from the 2019 American Community Survey. Results: A total of 760 044 adults met the study inclusion criteria and 40% had pre-diabetes. Individuals in pre-diabetes hotspots were less likely to be non-Hispanic white (33.6% vs 50.6%, RD: −17.04%, 95% CI –17.26% to –16.81%, p<0.0001) and more likely to have overweight or obesity (72.2% vs 69.2%, RD: 2.95%, 95% CI 2.73% to 3.16%, p<0.0001). Census tracts within hotspots had lower levels of household income (HL estimate: −3651.00, 95% CI –7256.00 to –25.00), per cent of adults with bachelor’s degrees or higher (HL estimate: −9.08, 95% CI –10.94 to –7.24) and median home values (HL estimate: −113 200.00, 95% CI –140 600.00 to –85 700.00) and higher rates of household poverty (HL estimate: 0.96, 95% CI 0.55 to 1.37), unemployment (HL estimate: 0.39, 95% CI 0.24 to 0.54), household public assistance (HL estimate: 0.97, 95% CI 0.76 to 1.18) and per cent receiving Medicaid (HL estimate: 4.56, 95% CI 3.40 to 5.76) (p<0.05 for all). Conclusions: We found that individual-level and census tract-level socioeconomic status, obesity prevalence and race and ethnicity categories of patients living in pre-diabetes hotspots differed from those not identified as a hotspot. Policy-makers and care providers can use this information to target diabetes prevention resources and outreach by enacting policies that provide insurance coverage for low-income populations and placing diabetes prevention programmes in communities with highest need.
- Open Access
- 30 November 2024
- Published by Elsevier in Journal of Obstetric, Gynecologic, & Neonatal Nursing
- Vol. 54 (1) , 32-37.e3
Feasibility and Acceptability of the We See You, Sis Sister Circle for Black Women With Depression Symptoms
- 30 November 2024
- Published by Elsevier in Journal of Obstetric, Gynecologic, & Neonatal Nursing
- Vol. 54 (1) , 32-37.e3
Open AccessFeasibility and Acceptability of the We See You, Sis Sister Circle for Black Women With Depression Symptoms
- Open Access
- 19 October 2024
- Published by Springer Nature in npj Digital Medicine
- Vol. 7 (1) , 1-12
Guidance for unbiased predictive information for healthcare decision-making and equity (GUIDE): considerations when race may be a prognostic factor
Clinical prediction models (CPMs) are tools that compute the risk of an outcome given a set of patient characteristics and are routinely used to inform patients, guide treatment decision-making, and resource allocation. Although much hope has been placed on CPMs to mitigate human biases, CPMs may potentially contribute to racial disparities in decision-making and resource allocation. While some policymakers, professional organizations, and scholars have called for eliminating race as a variable from CPMs, others raise concerns that excluding race may exacerbate healthcare disparities and this controversy remains unresolved. The Guidance for Unbiased predictive Information for healthcare Decision-making and Equity (GUIDE) provides expert guidelines for model developers and health system administrators on the transparent use of race in CPMs and mitigation of algorithmic bias across contexts developed through a 5-round, modified Delphi process from a diverse 14-person technical expert panel (TEP). Deliberations affirmed that race is a social construct and that the goals of prediction are distinct from those of causal inference, and emphasized: the importance of decisional context (e.g., shared decision-making versus healthcare rationing); the conflicting nature of different anti-discrimination principles (e.g., anticlassification versus antisubordination principles); and the importance of identifying and balancing trade-offs in achieving equity-related goals with race-aware versus race-unaware CPMs for conditions where racial identity is prognostically informative. The GUIDE, comprising 31 key items in the development and use of CPMs in healthcare, outlines foundational principles, distinguishes between bias and fairness, and offers guidance for examining subgroup invalidity and using race as a variable in CPMs. This GUIDE presents a living document that supports appraisal and reporting of bias in CPMs to support best practice in CPM development and use.
- 19 October 2024
- Published by Springer Nature in npj Digital Medicine
- Vol. 7 (1) , 1-12
Open AccessGuidance for unbiased predictive information for healthcare decision-making and equity (GUIDE): considerations when race may be a prognostic factor
Clinical prediction models (CPMs) are tools that compute the risk of an outcome given a set of patient characteristics and are routinely used to inform patients, guide treatment decision-making, and resource allocation. Although much hope has been placed on CPMs to mitigate human biases, CPMs may potentially contribute to racial disparities in decision-making and resource allocation. While some policymakers, professional organizations, and scholars have called for eliminating race as a variable from CPMs, others raise concerns that excluding race may exacerbate healthcare disparities and this controversy remains unresolved. The Guidance for Unbiased predictive Information for healthcare Decision-making and Equity (GUIDE) provides expert guidelines for model developers and health system administrators on the transparent use of race in CPMs and mitigation of algorithmic bias across contexts developed through a 5-round, modified Delphi process from a diverse 14-person technical expert panel (TEP). Deliberations affirmed that race is a social construct and that the goals of prediction are distinct from those of causal inference, and emphasized: the importance of decisional context (e.g., shared decision-making versus healthcare rationing); the conflicting nature of different anti-discrimination principles (e.g., anticlassification versus antisubordination principles); and the importance of identifying and balancing trade-offs in achieving equity-related goals with race-aware versus race-unaware CPMs for conditions where racial identity is prognostically informative. The GUIDE, comprising 31 key items in the development and use of CPMs in healthcare, outlines foundational principles, distinguishes between bias and fairness, and offers guidance for examining subgroup invalidity and using race as a variable in CPMs. This GUIDE presents a living document that supports appraisal and reporting of bias in CPMs to support best practice in CPM development and use.
- Open Access
- 28 September 2023
- Published by American Diabetes Association in Diabetes Care
- Vol. 46 (12) , 2218-2222
The Effectiveness of Shared Decision-making for Diabetes Prevention: 24- and 36-Month Results From the Prediabetes Informed Decision and Education (PRIDE) Trial
OBJECTIVE: We conducted a cluster-randomized, shared decision-making (SDM) trial offering lifestyle change, metformin, or both options, to adults at risk for diabetes in a primary care network (n = 20 practices). RESEARCH DESIGN AND METHODS: We used propensity score matching to identify control patients and used electronic health record data to compare weight loss at 24 and 36 months of follow-up and diabetes incidence at 36 months of follow-up. RESULTS: In adjusted post hoc analyses, SDM participants (n = 489) maintained modestly greater 24-month weight loss of −3.1 lb and 36-month weight loss of −2.7 lb versus controls (n = 1,430, both comparisons P < 0.001). SDM participants who chose both lifestyle change and metformin sustained weight loss at 36 months of −4.1 lb (P < 0.001 vs. controls). We found no differences in incident diabetes (15% of SDM participants, 14% of control participants; P = 0.64). CONCLUSIONS: This is one of the first studies to demonstrate weight loss maintenance up to 36 months after diabetes prevention SDM.
- 28 September 2023
- Published by American Diabetes Association in Diabetes Care
- Vol. 46 (12) , 2218-2222
Open AccessThe Effectiveness of Shared Decision-making for Diabetes Prevention: 24- and 36-Month Results From the Prediabetes Informed Decision and Education (PRIDE) Trial
OBJECTIVE: We conducted a cluster-randomized, shared decision-making (SDM) trial offering lifestyle change, metformin, or both options, to adults at risk for diabetes in a primary care network (n = 20 practices). RESEARCH DESIGN AND METHODS: We used propensity score matching to identify control patients and used electronic health record data to compare weight loss at 24 and 36 months of follow-up and diabetes incidence at 36 months of follow-up. RESULTS: In adjusted post hoc analyses, SDM participants (n = 489) maintained modestly greater 24-month weight loss of −3.1 lb and 36-month weight loss of −2.7 lb versus controls (n = 1,430, both comparisons P < 0.001). SDM participants who chose both lifestyle change and metformin sustained weight loss at 36 months of −4.1 lb (P < 0.001 vs. controls). We found no differences in incident diabetes (15% of SDM participants, 14% of control participants; P = 0.64). CONCLUSIONS: This is one of the first studies to demonstrate weight loss maintenance up to 36 months after diabetes prevention SDM.